Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Chipscreen Biosciences Announces a Collaboration with Innovent to Evaluate Chidamide and the Combination of Sintilimab, Anti-VEGF Monoclonal Antibody IBI305 in Colorectal Cancer patients 2019-02-18 10:08
Spring Pharmaceutical Group Inc. Reports Financial Results for the Three and Nine Months Ended December 31, 2018 2019-02-15 05:15
Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in the United States 2019-02-13 20:30
GC Pharma Reports Full Year 2018 Results 2019-02-12 22:00
Bridge Biotherapeutics Presented Preclinical and Phase I Study Results for BBT-401 at the Crohn's & Colitis Congress 2019-02-11 22:00
3SBio and Verseau Establish Global Clinical Development Collaboration for First-in-class Immuno-Oncology Therapies 2019-02-11 20:18
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare 2019-02-11 18:30
CStone and IMPACT Therapeutics' clinical collaboration progresses to IND filing acceptance for CS1001+IMP4297 combination therapy 2019-02-08 03:10
Taiho Pharmaceutical and Cullinan Oncology Establish Collaboration to Develop TAS6417, Novel EGFR Tyrosine Kinase Inhibitor 2019-02-05 16:00
GeneQuantum Healthcare and MITRO Biotech Enter into Strategic Cooperation to Develop Next Generation Radionuclide Conjugates 2019-02-03 20:00
I-Mab Biopharma and Bio-Cancer Treatment International Announce Intention for Collaboration on Arginine Depletion Therapy and Biomarker Study, with Plans for I-Mab to Establish a Translational Medicine Lab in Hong Kong 2019-02-01 17:46
TOLSURA (TM) (SUBA®-itraconazole) Antifungal Capsule Now Available in the United States 2019-01-30 20:30
CARsgen Therapeutics Receives IND Clearance for GPC3-CAR-T Cells from the NMPA 2019-01-29 18:00
CStone receives CTA approval in China to start Phase I trial for FGFR4 inhibitor BLU-554 (CS3008) 2019-01-29 10:19
I-Mab Receives IND Approval from the US FDA to Initiate Clinical Trials for Its Proprietary TJC4, a Potential Global Best-in-Class Anti-CD47 Monoclonal Antibody 2019-01-28 21:58
I-Mab Biopharma Receives U.S. FDA IND Clearance for Proprietary CD73 Antibody TJD5 2019-01-22 22:04
TaiwanJ Pharmaceuticals Announces Positive Results from Phase 2 Orphan Drug Designation Study of JKB-122 on Autoimmune Hepatitis (AIH) 2019-01-22 10:45
OliX Announces Clinical Candidate Nomination for the Treatment of Geographic Atrophy 2019-01-18 14:50
Luye Pharma Reaches Strategic Partnership with AstraZeneca, Strengthens Commitment to Cardiovascular Therapeutic Field 2019-01-16 19:08
/CORRECTION/ -- NapaJen Pharma, Inc./ 2019-01-09 21:52
1 126 127 128 129 130 158